日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Antibody conjugation of paclitaxel enables aqueous compatibility and enhances tumor-targeted efficacy in vitro and in vivo

紫杉醇抗体偶联可提高其水性相容性，并增强体外和体内肿瘤靶向疗效。

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2026.1805542
Rana, Gul E; Yang, Shufan; He, Yanting; Qiu, Chengcheng; Long, Jing; Huang, Yezhen; Liu, Wenjing; Luo, Jincheng; Zhu, Jindi; Xu, Siwen; Wang, Qi; Wang, Chun-He
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Physically engineered extracellular vesicles targeted delivering miR-21-5p to promote renoprotection after renal ischemia-reperfusion injury

物理工程改造的细胞外囊泡靶向递送 miR-21-5p 以促进肾缺血再灌注损伤后的肾脏保护

期刊:Materials Today Bio
影响因子:8.7
doi:10.1016/j.mtbio.2025.101528
Di Wu, Wenjie Ma, Liucheng Wang, Chengcheng Long, Silin Chen, Jingyu Liu, Yiguan Qian, Jun Zhao, Changcheng Zhou, Ruipeng Jia
免疫
细胞生物学
其它细胞
IGG1
发表日期：2025
文献求助 收藏

LncRNA LUCAT1 as a prognostic biomarker in cholangiocarcinoma through targeting miR-141-3p: clinical and functional insights

lncRNA LUCAT1通过靶向miR-141-3p作为胆管癌的预后生物标志物：临床和功能见解

期刊:Hereditas
影响因子:2.5
doi:10.1186/s41065-025-00512-6
An, Yuxin; Chen, Qing; Zhou, Shanshan; Ying, Chengcheng; Long, Guanbao; Hu, Zouxiao; Sun, Jiangyang; Zhang, Niu
肿瘤
胆管癌
肿瘤免疫
lncRNA
发表日期：2025
文献求助 收藏